Executive Profile

Carl C. Peck M.D., Dr h.c. (Uppsala) Founder, Manager, and Chairman, NDA Partners LLC

Age	Total Calculated Compensation	This person is connected to 6 Board Members in 6 different organizations across 9 different industries. See Board Relationships
70	--

Background

Dr. Carl C. Peck M.D., Dr h.c. (Uppsala) founded NDA Partners LLC in 2003 and serves as Manager and Chairman. Dr. Peck has been Professor of Pharmacology and Medicine and Director of the Center for Drug Development Science at Georgetown University Medical Center since September 1994. Dr. Peck is Professor of Anesthesia and Medicine, Investigator, CVRI, University of California, San Francisco. Dr. Peck is expertise in Clinical regulatory and development strategy areas. ... He served as Boerhaave Professor of Clinical Drug Research at Leiden University from November 1993 to July 1995. He held a number of academic positions prior to October 1987, including Professor of Medicine and Pharmacology at Uniformed Services University, from 1982 to October 1987 and its Director of the Division of Clinical Pharmacology since 1980. Dr. Peck joined the Food and Drug Administration (FDA) as Director, Center for Drug Evaluation and Research in October 1987 and was promoted to Assistant Surgeon General in the Public Health Service in October 1990 and retiring from FDA in late November 1993. He serves as Director and Member of Scientific Advisory Board at DermTech International. Dr. Peck is a Director of two private companies. He serves as Member of Proprietary Products Strategic Advisory Board at Nektar Therapeutics. He serves as Member of Scientific Advisory Board at Supernus Pharmaceuticals, Inc. and Simcyp Ltd. He serves as Member of Scientific Advisory and Regulatory Advisory Board at Ascend Therapeutics, Inc. He served as Member of Scientific Advisory Board at RealAge, Inc. He served as a Member of Scientific & Clinical Advisory Board at Renovo Group plc. He served as Director of Ligand Pharmaceuticals Inc. from May 1997 to March 1, 2007. In 1999, Dr. Peck received the FDA Distinguished Alumnus Award. He is an author of more than 100 original research papers, chapters and books. He undertook a research fellowship in clinical pharmacology at the University of California, San Francisco (1972-74). Dr. Peck holds an M.D. (1968) and a B.S. (1963), both from the University of Kansas, as well as an Honorary Doctorate from the University of Uppsala in January 2002.

Corporate Headquarters 312 Grove Avenue Falls Church, Virginia 22046 United States Phone: 703-919-1284 Fax: 703-536-7859 Board Members Memberships Director and Member of Scientific Advisory Board DermTech International 1997-2007 Former Director and Chairman of Science & Technology Committee Ligand Pharmaceuticals Incorporated Education BA 1963 University of Kansas BS University of Kansas MD University of Kansas Honorary Doctorate Uppsala Universitet Other Affiliations Nektar Therapeutics Ligand Pharmaceuticals Incorporated Supernus Pharmaceuticals, Inc. Renovo Group plc DermTech International Ascend Therapeutics, Inc. University of Kansas RealAge, Inc. Uppsala Universitet Simcyp Ltd.

Annual Compensation There is no Annual Compensation data available. Stocks Options There is no Stock Options data available. Total Compensation There is no Total Compensation data available.

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.